DOT follow-up testing management & reporting • Owner-operator and employer support • Call 407-859-1880
Home / Drug Testing / Follow-Up Management
DOT follow-up program support

Your SAP sets the plan. We keep it moving.

HealthRoute coordinates SAP-prescribed follow-up drug and alcohol testing for owner-operators and employers—from confidential scheduling and DOT-compliant collections to record management and applicable FMCSA Clearinghouse reporting.

49 CFR Part 40 supportConfidential schedulingClear records
A simple operating path

From SAP plan to documented completion

Follow-up programs can span months or years. HealthRoute provides the administrative structure to keep every required test organized without disclosing the schedule to the driver.

01

Send the SAP plan

We collect the written plan directly from the SAP or authorized party and confirm the required test types, frequency, and duration.

02

Authorize HealthRoute

The owner-operator designates HealthRoute as C/TPA and provides the required electronic Clearinghouse consent.

03

Complete each test

We select confidential dates, issue the notification, and coordinate DOT-compliant directly observed collections.

04

Track and report

Results and remaining requirements stay organized through completion, with applicable FMCSA reporting handled.

Program details

Clear service. Clear responsibilities.

Included in management

  • SAP plan intake
  • Confidential test scheduling
  • Drug and alcohol coordination
  • DOT-qualified collection sites
  • DOT chain-of-custody forms
  • Result and record management
  • Progress tracking
  • Applicable Clearinghouse reporting
Do not mix the programs

Follow-up testing is not random testing

They are separate DOT requirements. A random test cannot be substituted for a required follow-up test, and follow-up management alone does not enroll an owner-operator in a random consortium.

Follow-up testing
Random testing
Why it occursFollows a DOT violation and successful return-to-duty process.
Why it occursOngoing selection from a compliant random testing pool.
Who sets itThe SAP determines test type, number, frequency, and duration.
Who sets itSelections follow the applicable DOT agency testing rate.
EnrollmentCovered by a specific follow-up management agreement.
EnrollmentRequires separate consortium or employer program enrollment.
Compliance guardrails

The schedule stays confidential

DOT rules require follow-up tests to be unannounced and unpredictable. The driver is notified when it is time to report, not given the future testing calendar.

SAP

The SAP controls the plan

Only the SAP determines how many tests are required, how often they occur, and whether they cover drugs, alcohol, or both.

6+

At least six in the first year

The plan must require at least six unannounced follow-up tests in the first 12 months of safety-sensitive duty and may continue up to 60 months.

ID

Electronic consent still matters

A written authorization does not replace the electronic consent required through the FMCSA Drug & Alcohol Clearinghouse.

Questions, answered

Return-to-duty & follow-up testing FAQ

For FMCSA-regulated CDL drivers: understand SAP evaluations, return-to-duty testing, Clearinghouse status, and your follow-up responsibilities.

If you receive a verified positive DOT drug test result, you are immediately prohibited from performing DOT safety-sensitive duties, including operating a commercial motor vehicle. Your violation is reported to the FMCSA Drug and Alcohol Clearinghouse. Before returning to safety-sensitive work, you must successfully complete the DOT return-to-duty process. This generally involves an evaluation by a DOT-qualified Substance Abuse Professional (SAP), completing the SAP's recommendations, and passing the required return-to-duty test.

A SAP is a specially qualified professional who evaluates drivers who have violated DOT drug or alcohol regulations. The SAP determines what education or treatment you must complete before becoming eligible for return-to-duty testing. The SAP also establishes a follow-up testing plan that must be followed after you return to DOT safety-sensitive work.

You may meet with a DOT-qualified SAP either in person or through an approved real-time video evaluation, depending on the SAP's professional judgment and applicable licensing requirements. A regular telephone call without video does not satisfy the DOT face-to-face evaluation requirement. Both the initial evaluation and subsequent SAP follow-up evaluation may be performed through qualifying video technology.

The DOT process requires an initial SAP evaluation and a subsequent SAP follow-up evaluation. During the initial evaluation, the SAP assesses your situation and recommends education or treatment. After completing the recommended program, you meet with the SAP again. The SAP determines whether you have successfully complied with the recommendations. Additional counseling, treatment sessions, or other appointments may be necessary depending on your individual circumstances.

There is no universal timeline. Some drivers may complete their required education or treatment relatively quickly, while others may require a longer period of counseling or treatment. The SAP determines the appropriate requirements based on each driver's assessment. Completing a class or attending one appointment does not automatically qualify you for return-to-duty testing.

A return-to-duty drug test is a federally regulated test required after certain DOT drug or alcohol violations. It is performed after the SAP determines that you have successfully complied with the required education or treatment recommendations. For a drug violation, the return-to-duty drug test must produce a verified negative result before you can resume DOT safety-sensitive duties. DOT return-to-duty urine drug tests must be conducted under direct observation.

No. You must first complete the education or treatment recommended by the SAP and receive the SAP's determination that you have successfully complied. Only then can the return-to-duty test be arranged through the appropriate employer or authorized C/TPA. A negative drug test taken independently before SAP clearance does not substitute for a properly authorized DOT return-to-duty test.

Yes. FMCSA permits an eligible driver who has no current or prospective employer subject to its drug and alcohol testing regulations to designate a consortium/third-party administrator (C/TPA) for the limited purpose of completing the return-to-duty process. The driver must follow FMCSA's special Clearinghouse registration and C/TPA designation procedures. After the properly authorized return-to-duty test is negative and the result is reported, the driver's Clearinghouse status can change to "Not Prohibited." The driver will still have outstanding follow-up testing responsibilities.

Not completely. After the required SAP steps and a properly reported negative return-to-duty test, your Clearinghouse status generally changes from "Prohibited" to "Not Prohibited." However, your previous violation remains on your Clearinghouse record for the applicable retention period, and your follow-up testing requirements remain outstanding. "Not Prohibited" does not mean the original violation has been erased or that all federal follow-up obligations are complete.

Yes, provided you are legally eligible to perform the required duties. A trucking company may choose to hire a driver who has a previous DOT violation and has successfully completed the necessary return-to-duty steps. If you still have an outstanding SAP follow-up testing plan, the employer must ensure that the plan is properly administered when you return to DOT safety-sensitive work. Individual employers may also have their own hiring policies.

Return-to-duty testing is the test required after SAP clearance and before resuming DOT safety-sensitive work. Follow-up testing consists of additional, unannounced tests required by the SAP after you return to safety-sensitive duties. A successful return-to-duty test removes the federal prohibition when properly reported, but it does not eliminate the driver's follow-up testing obligations.

Federal DOT regulations require the SAP to prescribe a minimum of six unannounced follow-up tests during the first 12 months of safety-sensitive duty after the driver returns to work. Six tests is the minimum, not necessarily the total number required. The SAP may require additional tests or continue follow-up testing for as long as 60 months of safety-sensitive duty. The specific testing requirements are determined by the SAP.

No, not simply by purchasing or scheduling six tests while unemployed. FMCSA states that the SAP-prescribed follow-up testing plan must be administered when the driver resumes working in a DOT safety-sensitive position. Follow-up tests are tied to safety-sensitive duty, not merely to the passage of calendar time. An unemployed driver may be eligible to complete the return-to-duty test through a designated C/TPA, but this special allowance does not authorize completion of the entire follow-up plan while remaining out of covered safety-sensitive work.

Yes, a qualified C/TPA may coordinate and administer DOT follow-up testing on behalf of a covered employer. For a company-employed driver, the employer remains responsible for ensuring compliance with the SAP-prescribed follow-up plan. A genuine owner-operator operating in covered safety-sensitive duties must use a designated C/TPA to administer applicable DOT testing responsibilities. However, simply registering with a C/TPA does not allow an unemployed individual to complete the follow-up testing plan without performing covered safety-sensitive work.

Yes. All DOT return-to-duty and follow-up urine drug tests must be conducted under direct observation in accordance with federal testing procedures. This means an authorized observer directly watches the specimen collection process as required by DOT regulations. An ordinary, unobserved drug test does not satisfy the federally required return-to-duty or follow-up urine drug testing requirement.

No. DOT follow-up tests must be unannounced. The driver should not know the specific dates of upcoming follow-up tests in advance. The employer or its authorized administrator coordinates the testing schedule in accordance with the SAP's written requirements. Drivers should be prepared to report for testing when properly notified.

Your follow-up testing obligation does not disappear. Under DOT regulations, the follow-up plan follows the driver through employment changes and breaks in service. For example, if you complete two required follow-up tests and then become unemployed, you will still owe the remaining tests when you resume covered safety-sensitive work. Your new employer must ensure the outstanding SAP requirements are satisfied.

Yes. Your follow-up testing plan follows you to your next DOT-regulated employer. The new employer becomes responsible for administering the remaining testing requirements when you resume safety-sensitive work. Changing employers does not automatically restart your SAP process, erase previously completed compliant tests, or cancel outstanding follow-up testing requirements.

A violation remains in the Clearinghouse for five years from the date of the violation determination or until the driver successfully completes the return-to-duty process and all required follow-up testing, whichever is later. For example, if your follow-up testing requirements remain incomplete after five years, the violation may continue to appear in your Clearinghouse record. Successfully completing the return-to-duty test alone does not immediately remove the violation history.

Start by checking your FMCSA Clearinghouse status. If your return-to-duty process is incomplete, you should:

  1. Select and designate a DOT-qualified Substance Abuse Professional (SAP).
  2. Complete the initial SAP evaluation.
  3. Complete the education or treatment prescribed by the SAP.
  4. Attend the SAP follow-up evaluation.
  5. Receive the SAP's determination that you are eligible for return-to-duty testing.
  6. Arrange a properly authorized DOT return-to-duty test through an employer or, if eligible, a designated C/TPA.
  7. Obtain the required negative return-to-duty result and ensure it is properly reported to the Clearinghouse.
  8. When you resume covered safety-sensitive work, complete your SAP-prescribed follow-up testing plan under the responsible employer or, where applicable, an owner-operator's designated C/TPA.

Remember: Completing your return-to-duty test and completing your follow-up testing plan are two different federal requirements.

No. The Substance Abuse Professional is the sole determiner of the test type, number, frequency, and duration. HealthRoute administers the written plan.

No. Follow-up drug tests are $90 each and alcohol tests are $55 each under the current agreement. Testing fees are billed separately from annual management.

No. Follow-up and random testing are separate. Owner-operators who need random testing must maintain a separate DOT consortium enrollment.

HealthRoute maintains the program record and reports applicable completion information to the FMCSA Clearinghouse. Completion reporting requirements depend on the driver and employer circumstances.

Official guidance: DOT SAP evaluations · Follow-up plans · Employer responsibilities · Observed urine collections · FMCSA return-to-duty guidance · Clearinghouse records

Ready for organized follow-up management?

Enroll securely, provide your SAP information, and keep a card on file for future testing fees.